Gemvax Overview

  • Founded
  • 2001

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Gemvax General Information

Description

Developer and manufacturer of pharmaceutical products. The company is focused on the development of peptide vaccines, which are innovative immunotherapeutic anti-cancer drugs.

Contact Information

Website
www.gemvax.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Teknologisenteret
  • Kjølnes Ring
  • 3918 Porsgrunn
  • Norway

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemvax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gemvax‘s full profile, request access.

Request a free trial

Gemvax Patents

Gemvax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2002307645-A1 Polypeptides derived from human telomerase reverse transcriptase Inactive 21-May-2001
AU-2002248083-A1 A method for transfection of rna using electrical pulses Inactive 04-May-2001
CA-2446036-A1 A method for transfection of rna using electrical pulses Inactive 04-May-2001 000000000
EP-1390512-A1 A method for transfection of rna using electrical pulses Inactive 04-May-2001 000000000
GB-0111015-D0 Genetic material Inactive 04-May-2001 C12N15/87
To view Gemvax’s complete patent history, request access »

Gemvax Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gemvax‘s full profile, request access.

Request a free trial

Gemvax Subsidiaries (1)

Company Name Industry Location Founded
00000000 Construction and Engineering Daejeon, South Korea 0000
To view Gemvax’s complete subsidiaries history, request access »